Loading…
Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case
We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the...
Saved in:
Published in: | Journal of mathematical biology 2017-03, Vol.74 (4), p.809-841 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113 |
---|---|
cites | cdi_FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113 |
container_end_page | 841 |
container_issue | 4 |
container_start_page | 809 |
container_title | Journal of mathematical biology |
container_volume | 74 |
creator | Fermin, Lisandro J. Lévy Véhel, Jacques |
description | We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the results given in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39,
2013
), that dealt with the multi-IV bolus case. Under the assumption that the irregular dosing schedule follows a Poisson law, we study features of the drug concentration that have practical implications, such as its variability and the regularity of its cumulative probability distribution, which describes its predictive power with respect to the mean behaviour. We consider four variants: continuous-time, with either deterministic or random doses, and discrete-time, also with either deterministic or random doses. Our computations allow one to assess in a precise way the effect of various significant parameters such as the mean rate of intake, the elimination rate, the absorption rate and the mean dose. They quantify how much poor adherence will affect the efficacy of therapy. To appreciate this impact, we provide detailed comparisons with the variability of concentration in two reference situations: a fully adherent patient and a population of fully adherent patients with log-normally distributed pharmacokinetic parameters. Besides, the discrete-time versions of our models reveal unexpected links with objects which have been studied in the mathematical literature under the name of infinite Bernoulli convolutions (Erdós, Am J Math 61:974-975,
1939
). This allows us to quantify the fact that, when the random dosing schedule is too sparse, the concentration behaves in a very erratic way. Our results complement the ones in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39,
2013
) and help understanding the consequences of poor adherence. They may have practical outcomes in terms of drug dosing and scheduling. |
doi_str_mv | 10.1007/s00285-016-1041-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00868621v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4313379501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhi0EotuFB-CCLHGBQ2DGdmKHW1VBu9JKXICr5ThO160TBzup1LcnUUqFkDhZM_78z1gfIW8QPiKA_JQBmCoLwKpAEFjgM7JDwVmBAqvnZAcceFEpZGfkPOdbAJRljS_JGZOCo5LVjtz9NMmbxgc_PVAztDT74WYOS3Otk19L2qXY0zHGRG3sx-DNYB31AzV0PJnUGxvv_OAmb2kfWxfo4fCZTidH-zlMvojJBGpNdq_Ii86E7F4_nnvy4-uX75fXxfHb1eHy4lhYIeqpKDtb25K3nZPAuUBlrIOqbG3TMNk4qURdSpSdsqzpGqlqA8yUDet4ya1A5HvyYcs9maDH5HuTHnQ0Xl9fHPXaA1CVqhjer-z7jR1T_DW7POneZ-tCMIOLc9aoWCVZDUv2nrz7B72NcxqWnyxUJWsOgouFwo2yKeacXPe0AYJerenNml6s6dWaXpd4-5g8N71rn1780bQAbAPycjXcuPTX6P-m_gZeRaEq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1867930434</pqid></control><display><type>article</type><title>Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case</title><source>Springer Link</source><creator>Fermin, Lisandro J. ; Lévy Véhel, Jacques</creator><creatorcontrib>Fermin, Lisandro J. ; Lévy Véhel, Jacques</creatorcontrib><description>We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the results given in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39,
2013
), that dealt with the multi-IV bolus case. Under the assumption that the irregular dosing schedule follows a Poisson law, we study features of the drug concentration that have practical implications, such as its variability and the regularity of its cumulative probability distribution, which describes its predictive power with respect to the mean behaviour. We consider four variants: continuous-time, with either deterministic or random doses, and discrete-time, also with either deterministic or random doses. Our computations allow one to assess in a precise way the effect of various significant parameters such as the mean rate of intake, the elimination rate, the absorption rate and the mean dose. They quantify how much poor adherence will affect the efficacy of therapy. To appreciate this impact, we provide detailed comparisons with the variability of concentration in two reference situations: a fully adherent patient and a population of fully adherent patients with log-normally distributed pharmacokinetic parameters. Besides, the discrete-time versions of our models reveal unexpected links with objects which have been studied in the mathematical literature under the name of infinite Bernoulli convolutions (Erdós, Am J Math 61:974-975,
1939
). This allows us to quantify the fact that, when the random dosing schedule is too sparse, the concentration behaves in a very erratic way. Our results complement the ones in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39,
2013
) and help understanding the consequences of poor adherence. They may have practical outcomes in terms of drug dosing and scheduling.</description><identifier>ISSN: 0303-6812</identifier><identifier>EISSN: 1432-1416</identifier><identifier>DOI: 10.1007/s00285-016-1041-1</identifier><identifier>PMID: 27431876</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Applications of Mathematics ; Drug Administration Schedule ; Humans ; Mathematical and Computational Biology ; Mathematics ; Mathematics and Statistics ; Models, Theoretical ; Patient Compliance ; Pharmacokinetics ; Probability</subject><ispartof>Journal of mathematical biology, 2017-03, Vol.74 (4), p.809-841</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><rights>Journal of Mathematical Biology is a copyright of Springer, 2017.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113</citedby><cites>FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113</cites><orcidid>0000-0003-2645-8231</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27431876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inria.hal.science/hal-00868621$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Fermin, Lisandro J.</creatorcontrib><creatorcontrib>Lévy Véhel, Jacques</creatorcontrib><title>Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case</title><title>Journal of mathematical biology</title><addtitle>J. Math. Biol</addtitle><addtitle>J Math Biol</addtitle><description>We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the results given in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39,
2013
), that dealt with the multi-IV bolus case. Under the assumption that the irregular dosing schedule follows a Poisson law, we study features of the drug concentration that have practical implications, such as its variability and the regularity of its cumulative probability distribution, which describes its predictive power with respect to the mean behaviour. We consider four variants: continuous-time, with either deterministic or random doses, and discrete-time, also with either deterministic or random doses. Our computations allow one to assess in a precise way the effect of various significant parameters such as the mean rate of intake, the elimination rate, the absorption rate and the mean dose. They quantify how much poor adherence will affect the efficacy of therapy. To appreciate this impact, we provide detailed comparisons with the variability of concentration in two reference situations: a fully adherent patient and a population of fully adherent patients with log-normally distributed pharmacokinetic parameters. Besides, the discrete-time versions of our models reveal unexpected links with objects which have been studied in the mathematical literature under the name of infinite Bernoulli convolutions (Erdós, Am J Math 61:974-975,
1939
). This allows us to quantify the fact that, when the random dosing schedule is too sparse, the concentration behaves in a very erratic way. Our results complement the ones in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39,
2013
) and help understanding the consequences of poor adherence. They may have practical outcomes in terms of drug dosing and scheduling.</description><subject>Applications of Mathematics</subject><subject>Drug Administration Schedule</subject><subject>Humans</subject><subject>Mathematical and Computational Biology</subject><subject>Mathematics</subject><subject>Mathematics and Statistics</subject><subject>Models, Theoretical</subject><subject>Patient Compliance</subject><subject>Pharmacokinetics</subject><subject>Probability</subject><issn>0303-6812</issn><issn>1432-1416</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kcFu1DAQhi0EotuFB-CCLHGBQ2DGdmKHW1VBu9JKXICr5ThO160TBzup1LcnUUqFkDhZM_78z1gfIW8QPiKA_JQBmCoLwKpAEFjgM7JDwVmBAqvnZAcceFEpZGfkPOdbAJRljS_JGZOCo5LVjtz9NMmbxgc_PVAztDT74WYOS3Otk19L2qXY0zHGRG3sx-DNYB31AzV0PJnUGxvv_OAmb2kfWxfo4fCZTidH-zlMvojJBGpNdq_Ii86E7F4_nnvy4-uX75fXxfHb1eHy4lhYIeqpKDtb25K3nZPAuUBlrIOqbG3TMNk4qURdSpSdsqzpGqlqA8yUDet4ya1A5HvyYcs9maDH5HuTHnQ0Xl9fHPXaA1CVqhjer-z7jR1T_DW7POneZ-tCMIOLc9aoWCVZDUv2nrz7B72NcxqWnyxUJWsOgouFwo2yKeacXPe0AYJerenNml6s6dWaXpd4-5g8N71rn1780bQAbAPycjXcuPTX6P-m_gZeRaEq</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Fermin, Lisandro J.</creator><creator>Lévy Véhel, Jacques</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><general>Springer</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>M7Z</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0003-2645-8231</orcidid></search><sort><creationdate>20170301</creationdate><title>Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case</title><author>Fermin, Lisandro J. ; Lévy Véhel, Jacques</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Applications of Mathematics</topic><topic>Drug Administration Schedule</topic><topic>Humans</topic><topic>Mathematical and Computational Biology</topic><topic>Mathematics</topic><topic>Mathematics and Statistics</topic><topic>Models, Theoretical</topic><topic>Patient Compliance</topic><topic>Pharmacokinetics</topic><topic>Probability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fermin, Lisandro J.</creatorcontrib><creatorcontrib>Lévy Véhel, Jacques</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Biochemistry Abstracts 1</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Journal of mathematical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fermin, Lisandro J.</au><au>Lévy Véhel, Jacques</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case</atitle><jtitle>Journal of mathematical biology</jtitle><stitle>J. Math. Biol</stitle><addtitle>J Math Biol</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>74</volume><issue>4</issue><spage>809</spage><epage>841</epage><pages>809-841</pages><issn>0303-6812</issn><eissn>1432-1416</eissn><abstract>We propose a stochastic model for the drug concentration in the case of multiple oral doses and in a situation of poor patient adherence. Our model is able to take into account an irregular drug intake schedule. This article is the second in a series of three. It presents a multi-oral version of the results given in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39,
2013
), that dealt with the multi-IV bolus case. Under the assumption that the irregular dosing schedule follows a Poisson law, we study features of the drug concentration that have practical implications, such as its variability and the regularity of its cumulative probability distribution, which describes its predictive power with respect to the mean behaviour. We consider four variants: continuous-time, with either deterministic or random doses, and discrete-time, also with either deterministic or random doses. Our computations allow one to assess in a precise way the effect of various significant parameters such as the mean rate of intake, the elimination rate, the absorption rate and the mean dose. They quantify how much poor adherence will affect the efficacy of therapy. To appreciate this impact, we provide detailed comparisons with the variability of concentration in two reference situations: a fully adherent patient and a population of fully adherent patients with log-normally distributed pharmacokinetic parameters. Besides, the discrete-time versions of our models reveal unexpected links with objects which have been studied in the mathematical literature under the name of infinite Bernoulli convolutions (Erdós, Am J Math 61:974-975,
1939
). This allows us to quantify the fact that, when the random dosing schedule is too sparse, the concentration behaves in a very erratic way. Our results complement the ones in Lévy-Véhel and Lévy-Véhel (J Pharmacokinet Pharmacodyn 40(1):15–39,
2013
) and help understanding the consequences of poor adherence. They may have practical outcomes in terms of drug dosing and scheduling.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27431876</pmid><doi>10.1007/s00285-016-1041-1</doi><tpages>33</tpages><orcidid>https://orcid.org/0000-0003-2645-8231</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0303-6812 |
ispartof | Journal of mathematical biology, 2017-03, Vol.74 (4), p.809-841 |
issn | 0303-6812 1432-1416 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_00868621v1 |
source | Springer Link |
subjects | Applications of Mathematics Drug Administration Schedule Humans Mathematical and Computational Biology Mathematics Mathematics and Statistics Models, Theoretical Patient Compliance Pharmacokinetics Probability |
title | Variability and singularity arising from poor compliance in a pharmacokinetic model II: the multi-oral case |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T08%3A14%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Variability%20and%20singularity%20arising%20from%20poor%20compliance%20in%20a%20pharmacokinetic%20model%20II:%20the%20multi-oral%20case&rft.jtitle=Journal%20of%20mathematical%20biology&rft.au=Fermin,%20Lisandro%20J.&rft.date=2017-03-01&rft.volume=74&rft.issue=4&rft.spage=809&rft.epage=841&rft.pages=809-841&rft.issn=0303-6812&rft.eissn=1432-1416&rft_id=info:doi/10.1007/s00285-016-1041-1&rft_dat=%3Cproquest_hal_p%3E4313379501%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c449t-5fc9c53dfe7033418ace065dcbb27be78495717f8c2bfb789a02a5b2f353c4113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1867930434&rft_id=info:pmid/27431876&rfr_iscdi=true |